Home to the Schaeffer Center for Health Policy & Economics / Schaeffer Fellows. Transforming policy through evidence-based research and engaged citizenship.
Joined October 2012
- Tweets 7,102
- Following 926
- Followers 2,014
- Likes 2,655
459 Photos and videos
Jun 12
Medicare could unlock a trove of valuable clinical trial data through relatively modest changes to reporting requirements, USC Schaeffer Scholars Sidra Haye and Mireille Jacobson write in @JAMAHealthForum.
schaeffer.usc.edu/research/i…
45
USC Schaeffer retweeted
Jun 10
Health care costs are putting pressure on families across the country, from rising insurance premiums to higher prescription and out-of-pocket expenses.
Erin Duffy of @USCSchaeffer shares why reviewing medical bills closely can make a real difference for patients facing unexpected charges.
Read the full story at the link in bio: uscprice.page/4uQ2gfC
ALT A stethoscope is placed on top of hundred dollar bills. The image is associated with a guide titled "How to Lower Your Health Care Costs" from Seniors Guide.
1
51
Jun 10
GLP-1s may deliver the greatest health and economic benefits to disadvantaged populations, who historically have faced greater barriers to sustained weight loss through behavioral interventions.
New NBER working paper from USC Schaeffer scholars ⬇️schaeffer.usc.edu/research/g…
70
“We do not lack cures. We lack the infrastructure to pay for and deliver them,” writes William Padula. trib.al/0qzotVW
4
4
8,069
Medicare’s cap on monthly #insulin costs reduced beneficiaries’ spending on the drug by 21% and increased use among those who previously had especially high costs, finds new USC Schaeffer research in JAMA. schaeffer.usc.edu/research/m…
38
At the FDA listening session, USC Schaeffer's Lowell Schiller said formal rules or guidance for the commissioner's voucher program would strengthen program integrity and provide greater certainty for product sponsors.
Patient advocates, former agency officials, and many industry players are urging the FDA to pause former commissioner Marty Makary's drug voucher program and reintroduce it through formal rulemaking: trib.al/KYNR5By
2
2
394
A Medicare policy providing coverage for promising treatments while more evidence is gathered has effectively created a two-tiered system for access to innovative medical technologies, new USC Schaeffer research shows. schaeffer.usc.edu/research/h…
51
Water and food insecurity are often seen as separate issues. However, people who lack clean drinking water also tend to struggle with food access & safety, new USC Schaeffer research finds.
The findings underscore the need for coordinated global action. schaeffer.usc.edu/research/l…
34
USC Schaeffer retweeted
May 28
Greater flexibility in cost-effectiveness thresholds used by health technology assessment bodies may appear manageable in isolation. But these shifts can reshape drug pricing far beyond national boundaries. | Forefront
William Padula | @USC
healthaffairs.org/do/10.1377…
1
397
May 27
Insured patients with higher cost-sharing on generic drugs can usually get a better deal through the Mark Cuban Cost Plus Drug Company, finds new research co-authored by USC Schaeffer's Erin Trish.
acpjournals.org/doi/10.7326/…
1
1
73
May 26
As #Alzheimers clinical trials target early, biomarker-defined stages of disease, eligibility depends on how reliably biomarkers can be assessed across populations.
New USC research on biomarker variability provides important nuance to this challenge.
schaeffer.usc.edu/research/a…
1
2
91
May 20
Traditional Medicare now spends $55B annually on medical care for beneficiaries with #dementia, with costs expected to grow as the population ages.
Our updated interactive data-viz makes it easy to explore how this spending has changed over two decades. schaeffer.usc.edu/research/d…
33
May 14
USC Schaeffer’s Dima Qato discusses her pharmacy mapping tool, which reveals where access has collapsed and highlights how policymakers can combat pharmacy deserts.
Her interview with @Drug_Topics ⤵️
drugtopics.com/view/how-phar…
1
42
A deal to embed a Massachusetts health system’s clinics inside CVS is unlikely to boost primary care access while weakening price competition in important but hard-to-measure ways, USC Schaeffer's John Romley tells @medcitynews.
medcitynews.com/2026/05/cvs-…
102
Declining civic participation is a threat to democracies worldwide, warns former UK PM Gordon Brown.
As chair of USC Schaeffer’s new Center for Civic Society, he says a renewed commitment to building community is essential to bolstering democracy.
🔗schaeffer.usc.edu/research/r…
2
2
137
USC Schaeffer's Geoffrey Joyce in the @nytimes discusses research suggesting that statins and drugs treating hypertension can reduce dementia risk. nytimes.com/2026/04/17/well/…
44
Mail-order pharmacy dispensing of mifepristone rose sharply after FDA lifted in-person requirements, now under Supreme Court review, USC Schaeffer researchers reported in @JAMA_current. schaeffer.usc.edu/research/a…
3
2,926
The structural divide between #MedicareAdvantage drug coverage and standalone #PartD plans is widening under IRA cost pressures, according to research from USC Schaeffer's Geoffrey Joyce. academic.oup.com/healthaffai…
72
Apr 29
A big obstacle to developing #Alzheimers treatments: slow & uneven trial recruitment.
The USC Clinical Trial Recruitment Lab convened leaders to share strategies that speed recruitment, strengthen trust & ensure representative enrollment.
Our report ⤵️ schaeffer.usc.edu/research/a…
1
1
2
73
Apr 28
About 1 in 3 kids and teens use dietary supplements, despite limited evidence of their safety and effectiveness, USC Schaeffer’s Dima Mazen Qato finds in new research.
healthday.com/healthday-tv/c…
67